Schedule 13G ownership disclosure

Celldex Therapeutics Inc

Security class unavailable · CUSIP: 15117B202

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,921,579
Percent of class
8.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-22-001595
Form type
SC 13G/A
Filer
Celldex Therapeutics, Inc.
CIK
CIK 744218
Filed
Feb 14, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub